Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- KERSLEY G. D., MANDEL L. Toxic effects of phenylbutazone. Lancet. 1953 May 23;1(6769):1046–1047. doi: 10.1016/s0140-6736(53)92188-6. [DOI] [PubMed] [Google Scholar]
- KUZELL W. C., SCHAFFARZICK R. W., NAUGLER W. E., KOETS P., MANKLE E. A., BROWN B., CHAMPLIN B. Some observations on 520 gouty patients. J Chronic Dis. 1955 Dec;2(6):645–669. doi: 10.1016/0021-9681(55)90193-4. [DOI] [PubMed] [Google Scholar]
- MAUER E. F. The toxic effects of phenylbutazone (butazolidin); review of the literature and report of the twenty-third death following its use. N Engl J Med. 1955 Sep 8;253(10):404–410. doi: 10.1056/NEJM195509082531003. [DOI] [PubMed] [Google Scholar]
- ROBINS H. M., LOCKIE L. M., NORCROSS B., RIORDAN D. J. Use of phenylbutazone in musculoskeletal disorders. Am Pract Dig Treat. 1957 Nov;8(11):1758–1762. [PubMed] [Google Scholar]
- STEINBROCKER O., BERKOWITZ S., EHRLICH M., ELKIND M., CARP S. Phenylbutazone therapy of arthritis and other painful musculoskeletal disorders. J Am Med Assoc. 1952 Nov 15;150(11):1087–1091. doi: 10.1001/jama.1952.03680110027008. [DOI] [PubMed] [Google Scholar]
- TOONE E. C., Jr, IRBY R. An evaluation of phenylbutazone (butazolidin) in the treatment of gout, rheumatoid spondylitis, rheumatoid arthritis and other conditions of the musculoskeletal system. South Med J. 1957 May;50(5):655–662. doi: 10.1097/00007611-195705000-00020. [DOI] [PubMed] [Google Scholar]
- TOONE E. C., Jr Phyenylbutazone (butazolidin). Bull Rheum Dis. 1955 Feb;5(6):83–84. [PubMed] [Google Scholar]